GLGLENVIEW CAPITAL MANAGEMENT, LLC
Institutional investor · Portfolio as of Q4 2024
Top Holdings36 positions
CVS HEALTH CORP | 11.9M | $536.3M | 13.6% | $57.60 | -26.97% | 5 qtrssince 2023-Q4 | Unchanged 0 |
GLOBAL PMTS INC | 3.9M | $440M | 11.1% | $124.24 | -11.75% | 17 qtrssince 2020-Q4 | Decreased 0 |
TENET HEALTHCARE CORP COM NEW | 2.8M | $358.1M | 9.1% | $40.38 | +212.57% | 25 qtrssince 2018-Q4 | Increased 65 |
ALIGHT INC | 31.9M | $220.8M | 5.6% | $7.59 | -13.57% | 10 qtrssince 2022-Q3 | Increased 92 |
TEVA PHARMACEUTICAL INDS LTD | 8.5M | $186.4M | 4.7% | $13.85 | +59.09% | 5 qtrssince 2023-Q4 | Unchanged 0 |
DUN & BRADSTREET HLDGS INC | 14.8M | $184.3M | 4.7% | — | — | 10 qtrssince 2022-Q3 | Increased 80 |
CIGNA CORP NEW | 632,408 | $174.6M | 4.4% | $230.05 | +15.66% | 25 qtrssince 2018-Q4 | Decreased 0 |
Expedia Group Inc | 878,580 | $163.7M | 4.1% | $119.61 | +54.66% | 10 qtrssince 2022-Q3 | Decreased 0 |
UNIVERSAL HLTH SVCS INC | 879,298 | $157.8M | 4.0% | $152.90 | +16.18% | 9 qtrssince 2022-Q4 | Increased 67 |
DXC TECHNOLOGY CO | 7.9M | $157.6M | 4.0% | $31.09 | -35.74% | 25 qtrssince 2018-Q4 | Decreased 0 |
CORTEVA INC | 2.1M | $117.1M | 3.0% | $51.00 | +9.77% | 21 qtrssince 2019-Q4 | Decreased 0 |
VIATRIS INC COM | 9.3M | $116.1M | 2.9% | $10.15 | +14.03% | 5 qtrssince 2023-Q4 | Increased 63 |
US Foods Holding Corp | 1.6M | $108.5M | 2.7% | $41.72 | +61.69% | 13 qtrssince 2021-Q4 | Decreased 0 |
ZOOMINFO TECHNOLOGIES INC COMMON STOCK | 10M | $105M | 2.7% | $10.80 | -3.67% | 3 qtrssince 2024-Q2 | Increased 84 |
CLARIVATE PLC | 18.6M | $94.3M | 2.4% | $9.07 | -44.23% | 11 qtrssince 2022-Q2 | Decreased 0 |
MCKESSON CORP | 151,618 | $86.4M | 2.2% | $146.03 | +289.20% | 25 qtrssince 2018-Q4 | Decreased 0 |
Uber Technologies Inc | 1.4M | $83.9M | 2.1% | $47.81 | +27.10% | 15 qtrssince 2021-Q2 | Increased 66 |
CENTENE CORP DEL | 1.3M | $78M | 2.0% | $60.58 | 0.00% | 1 qtr | New 69 |
Amazon.com, Inc. | 333,325 | $73.1M | 1.8% | $140.85 | +55.77% | 8 qtrssince 2023-Q1 | Decreased 0 |
KNIGHT SWIFT TRANSN HLDGS IN | 1.2M | $63.9M | 1.6% | $50.67 | +2.17% | 8 qtrssince 2023-Q1 | Decreased 0 |
GLENVIEW CAPITAL MANAGEMENT, LLC manages $4B across 36 positions as of Q4 2024. Top holdings: CVS (13.6%), GPN (11.1%), THC (9.1%). Fund DNA: Balanced Allocator. HoldingsIntel Score: 3/5.0.
Active quarter - 5 new positions, 12 exits, 12 increased. Top move: ALIT (INCREASED, conviction 92). Portfolio: $4.0B across 36 positions.
Top holdings by portfolio weight
Portfolio allocation by GICS sector
Behavioral investing profile
Position Outcomes
Best and worst performing positions by estimated return
Top Winners
Top Losers
Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.
Similar Funds
Funds with similar investing DNA
Explore More
Accumulation Streaks
Positions with 2+ consecutive quarters of increases - persistent directional conviction.
Continue exploring
Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer
Verify source filings on SEC EDGAR